Alabaster set to accept School Board applications

Published 10:50 am Wednesday, January 24, 2018

By NEAL WAGNER / Managing Editor

ALABASTER – Alabaster residents looking to serve on the city’s school board will have a chance to apply for a seat over the next month, as the City Council looks to make a five-year appointment in April.

Each year, the City Council votes to either reappoint a current School Board member or to appoint a new member to the board on a rotating basis.

During a recent meeting, the City Council announced it would start accepting applications for one seat on the School Board on Feb. 1. The city will accept applications through March 1 before interviewing the finalists for the position in March and appointing someone to the five-year term in April.

School Board member Ty Quarles currently occupies the seat, and the City Council will decide if it will reappoint Quarles or appoint someone new to the seat.

Quarles originally was appointed to the School Board in 2012, and was reappointed to the seat after his original term expired in 2013. His current term will expire in June.

After reappointing Quarles to a five-year term in 2013, the council reappointed School Board member John Myrick through June 2019, School Board member Derek Henderson to a term ending in 2020, School Board member Linda Church to a term ending in June 2021 and School Board President Adam Moseley to a term ending in 2022.

The individual appointed or reappointed in April will serve on the School Board until June 2023.

Those interested in serving on the school board should visit Cityofalabaster.com/391/Board-of-Education-Application. The link will go live on Feb. 1.

Applicants must be Alabaster residents, and must be able to attend regular monthly School Board meetings and any special-called meetings.

Once the link goes live, applicants will be able to attach a résumé and a cover letter detailing their specific qualifications for the School Board. All final School Board applicants are subject to a background check and drug screening.